The effect of SNPs in CYP450 in chloroquine/primaquinePlasmodium vivaxmalaria treatment

Challenges for malaria elimination in Brazil

(2016) Marcelo U. Ferreira et al.   MALARIA JOURNAL

Geographical variation in Plasmodium vivax relapse

(2014) Katherine E Battle et al.   MALARIA JOURNAL

CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine

(2012) Brandon S Pybus et al.   MALARIA JOURNAL

IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil

(2012) Vinicius A Sortica et al.   MALARIA JOURNAL

Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians

(2010) G Suarez-Kurtz et al.   PHARMACOGENOMICS JOURNAL

Resistance to Therapies for Infection by Plasmodium vivax

(2009) J. K. Baird   CLINICAL MICROBIOLOGY REVIEWS

Polymorphism of human cytochrome P450 enzymes and its clinical impact

(2009) Shu-Feng Zhou et al.   DRUG METABOLISM REVIEWS

Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel

(2009) Ney P.C. Santos et al.   HUMAN MUTATION

Cytochrome P450-dependent toxic effects of primaquine on human erythrocytes

(2009) Shobana Ganesan et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Primaquine revisited six decades after its discovery

(2008) Nuno Vale et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY